tradingkey.logo

Integra Lifesciences Holdings Corp

IART
11.260USD
+0.380+3.49%
종가 02/06, 16:00ET시세는 15분 지연됩니다
876.42M시가총액
손실P/E TTM

Integra Lifesciences Holdings Corp

11.260
+0.380+3.49%

자세한 내용은 Integra Lifesciences Holdings Corp 회사

Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.

Integra Lifesciences Holdings Corp 정보

종목 코드 IART
회사 이름Integra Lifesciences Holdings Corp
상장일Aug 16, 1995
CEOPoul (Mojdeh)
직원 수4396
유형Ordinary Share
회계 연도 종료Aug 16
주소1100 Campus Road
도시PRINCETON
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호08540
전화16092750500
웹사이트https://www.integralife.com/
종목 코드 IART
상장일Aug 16, 1995
CEOPoul (Mojdeh)

Integra Lifesciences Holdings Corp의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
+26531.00%
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
89.14K
+19200.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
58.58K
-2561.00%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
35.79K
-4282.00%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
21.94K
+8684.00%
Dr. Stuart M. Essig, Ph.D.
Dr. Stuart M. Essig, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Robert T. Davis, Jr.
Mr. Robert T. Davis, Jr.
Executive Vice President, President - Tissue Technologies
Executive Vice President, President - Tissue Technologies
--
--
Ms. Barbara B. Hill
Ms. Barbara B. Hill
Independent Presiding Director
Independent Presiding Director
--
--
Mr. Eric I. Schwartz
Mr. Eric I. Schwartz
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
--
--
Mr. Michael J. Mcbreen
Mr. Michael J. Mcbreen
Executive Vice President, President - Codman Specialty Surgical
Executive Vice President, President - Codman Specialty Surgical
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
+26531.00%
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
89.14K
+19200.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
58.58K
-2561.00%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
35.79K
-4282.00%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
21.94K
+8684.00%
Dr. Stuart M. Essig, Ph.D.
Dr. Stuart M. Essig, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
--
--

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Neurosurgery
201.56M
50.13%
Wound Reconstruction and Care
83.99M
20.89%
Instruments
50.15M
12.47%
ENT
40.87M
10.16%
Private Label
25.49M
6.34%
지역별USD
이름
수익
비율
United States
295.85M
73.58%
Europe
42.89M
10.67%
Asia Pacific
42.68M
10.62%
Rest of World
20.64M
5.13%
사업별
지역별
사업별USD
이름
수익
비율
Neurosurgery
201.56M
50.13%
Wound Reconstruction and Care
83.99M
20.89%
Instruments
50.15M
12.47%
ENT
40.87M
10.16%
Private Label
25.49M
6.34%

주식 보유 통계

마지막 업데이트: Sat, Nov 15
마지막 업데이트: Sat, Nov 15
주주
주주 유형
주주
주주
비율
BlackRock Institutional Trust Company, N.A.
11.92%
TRU ST Partnership, L.P.
10.93%
Rubric Capital Management LP
9.83%
The Vanguard Group, Inc.
9.13%
Fuller & Thaler Asset Management Inc.
5.03%
기타
53.16%
주주
주주
비율
BlackRock Institutional Trust Company, N.A.
11.92%
TRU ST Partnership, L.P.
10.93%
Rubric Capital Management LP
9.83%
The Vanguard Group, Inc.
9.13%
Fuller & Thaler Asset Management Inc.
5.03%
기타
53.16%
주주 유형
주주
비율
Investment Advisor
36.64%
Investment Advisor/Hedge Fund
36.54%
Hedge Fund
18.48%
Corporation
10.93%
Individual Investor
3.20%
Research Firm
2.31%
Pension Fund
1.48%
Bank and Trust
0.40%
Sovereign Wealth Fund
0.04%

기관 주식 보유

마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
583
75.09M
96.41%
-24.67M
2025Q3
583
73.55M
94.42%
-25.07M
2025Q2
600
89.38M
114.72%
-18.72M
2025Q1
635
87.01M
111.97%
-18.30M
2024Q4
636
81.93M
106.10%
-20.27M
2024Q3
638
82.93M
106.93%
-12.58M
2024Q2
628
84.82M
107.92%
-1.75M
2024Q1
613
79.36M
101.18%
-3.69M
2023Q4
597
79.81M
101.26%
-5.74M
2023Q3
592
81.88M
100.31%
-3.94M
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
BlackRock Institutional Trust Company, N.A.
9.29M
11.92%
-146.58K
-1.55%
Sep 30, 2025
TRU ST Partnership, L.P.
8.52M
10.93%
--
--
Feb 28, 2025
Rubric Capital Management LP
7.65M
9.83%
+300.00K
+4.08%
Sep 30, 2025
The Vanguard Group, Inc.
7.29M
9.36%
-217.24K
-2.89%
Sep 30, 2025
Fuller & Thaler Asset Management Inc.
3.91M
5.03%
+21.91K
+0.56%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
3.18M
4.09%
+267.13K
+9.16%
Sep 30, 2025
Invesco Advisers, Inc.
3.18M
4.09%
+3.31K
+0.10%
Sep 30, 2025
State Street Investment Management (US)
2.79M
3.58%
-35.57K
-1.26%
Sep 30, 2025
Boston Management and Research
2.74M
3.52%
--
--
Sep 30, 2025
Paradigm Capital Management, Inc.
2.53M
3.25%
+348.30K
+15.97%
Sep 30, 2025
더 보기

관련 ETF

마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
iShares Neuroscience and Healthcare ETF
1.44%
State Street SPDR S&P Health Care Equipment ETF
1.39%
ROBO Global Healthcare Technology & Innovation ETF
1.02%
Invesco S&P SmallCap Health Care ETF
0.49%
Invesco NASDAQ Future Gen 200 ETF
0.43%
Inspire Small/Mid Cap ESG ETF
0.19%
Royce Quant Small-Cap Quality Value ETF
0.13%
Principal U.S. Small-Cap ETF
0.13%
iShares S&P Small-Cap 600 Value ETF
0.12%
State Street SPDR S&P 600 Small Cap Value ETF
0.11%
더 보기
iShares Neuroscience and Healthcare ETF
비율1.44%
State Street SPDR S&P Health Care Equipment ETF
비율1.39%
ROBO Global Healthcare Technology & Innovation ETF
비율1.02%
Invesco S&P SmallCap Health Care ETF
비율0.49%
Invesco NASDAQ Future Gen 200 ETF
비율0.43%
Inspire Small/Mid Cap ESG ETF
비율0.19%
Royce Quant Small-Cap Quality Value ETF
비율0.13%
Principal U.S. Small-Cap ETF
비율0.13%
iShares S&P Small-Cap 600 Value ETF
비율0.12%
State Street SPDR S&P 600 Small Cap Value ETF
비율0.11%

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
KeyAI